ctrl K

Watchlist Price Alert

Avenue Therapeutics Inc. (ATXI)

NASDAQ: ATXI · Real-Time Price · USD

0.20

-0.00 (-0.05%)

At close: Jun 09, 2025, 3:28 PM

Avenue Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-11.28M	-14.54M	-8.04M	-3.74M	-5.21M	-26.27M	-21.82M	-11.42M	-2.38M
Interest Income	-176K	126K	20K	7K	62K	357K	93K	88K	n/a
Pretax Income	-11.65M	-10.49M	-3.6M	-3.73M	-5.15M	-25.91M	-21.55M	-12.26M	-3.18M
Net Income	-11.65M	-10.38M	-3.55M	-3.72M	-5.09M	-25.55M	-21.28M	-12.26M	-3.18M
Selling & General & Admin	4.64M	4.18M	5.34M	2.48M	2.35M	3.07M	4.12M	3.62M	997K
Research & Development	6.64M	10.36M	2.7M	1.25M	2.87M	23.19M	17.7M	7.8M	1.38M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	175K	-99K	n/a
Operating Expenses	11.28M	14.54M	8.04M	3.74M	5.21M	26.27M	21.82M	11.42M	2.38M
Interest Expense	n/a	n/a	1.16M	n/a	n/a	n/a	n/a	375K	612K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	14.54M	8.04M	3.74M	5.21M	26.27M	21.82M	11.42M	2.38M
Income Tax Expense	n/a	n/a	-5.65M	-7K	-62K	-357K	-268K	287K	-1.76M
Shares Outstanding (Basic)	12.95M	141K	2.19M	1.13M	1.1M	1.05M	682.61K	442.33K	589.43K
Shares Outstanding (Diluted)	12.95M	141.22K	2.19M	1.13M	1.1M	1.05M	682.61K	442.33K	589.43K
EPS (Basic)	-0.9	-73.6	-1.63	-3.29	-4.62	-24.38	-31.17	-27.71	-5.39
EPS (Diluted)	-0.9	-73.48	-1.63	-3.29	-4.62	-24.38	-31.17	-27.71	-5.39
EBITDA	-11.28M	4.05M	-8.02M	n/a	-5.21M	n/a	n/a	n/a	-188K
EBIT	n/a	-10.49M	-3.6M	-3.73M	-5.15M	-25.91M	-21.55M	-11.88M	-2.56M
Depreciation & Amortization	n/a	14.54M	8.04M	3.74M	5.21M	26.27M	21.82M	11.42M	2.38M